Growth Metrics

Armata Pharmaceuticals (ARMP) FCF Margin (2016 - 2020)

Quarterly results put FCF Margin at 13319.35% for Q2 2020, changed N/A from a year ago — trailing twelve months through Jun 2020 was 13433.33% (changed N/A YoY), and the annual figure for FY2017 was 8043.48%, down 385694.0%.

Armata Pharmaceuticals has reported FCF Margin over the past 6 years, most recently at 13319.35% for Q2 2020.

  • FCF Margin reached 13319.35% in Q2 2020 per ARMP's latest filing, down from 11935.0% in the prior quarter.
  • Across five years, FCF Margin topped out at 1647.37% in Q3 2017 and bottomed at 13319.35% in Q2 2020.
  • Median FCF Margin over the past 3 years was 10475.0% (2017), compared with a mean of 8053.3%.
  • The largest annual shift saw FCF Margin crashed -906928bps in 2016 before it surged 924918bps in 2017.
  • Over 3 years, FCF Margin stood at 6868.18% in 2016, then tumbled by -74bps to 11935.0% in 2017, then fell by -12bps to 13319.35% in 2020.
  • Business Quant data shows FCF Margin for ARMP at 13319.35% in Q2 2020, 11935.0% in Q4 2017, and 1647.37% in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 43.35%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 23.53%
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 4.17%
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 -13,319.35%
Dec 31, 2017 -11,935.00%
Sep 30, 2017 -1,647.37%
Jun 30, 2017 -10,475.00%
Mar 31, 2017 -11,393.10%
Dec 31, 2016 -6,868.18%
Sep 30, 2016 -10,896.55%
Jun 30, 2016 -2,929.13%